ArticleScientific reports2026
Development and validation of a novel nomogram predicting axillary lymph node metastasis among breast cancer patients in Egypt.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Axillary lymph node dissection (ALND) remains widely used in the management of breast cancer in Egypt despite its association with significant morbidity. A reliable tool for predicting axillary lymph node metastasis (ALNM) could help reduce unnecessary surgical interventions. This study aimed to develop and validate a predictive nomogram to estimate the risk of ALNM in patients with breast cancer. We conducted a retrospective study of 1246 women with invasive breast cancer (stages I-III) treated at a tertiary center in Alexandria, Egypt (2018-2024). A perioperative, pathology-assisted model was developed as the primary tool, and a secondary, preoperative-only model was evaluated as a sensitivity analysis. A nomogram was constructed using multivariable logistic regression to predict ALNM, and model performance was assessed using the area under the ROC curve (AUC), calibration plots, and decision curve analysis (DCA). Five independent predictors of ALNM were identified. The primary model, which was developed using all clinically important and statistically significant variables, demonstrated excellent discrimination (AUC = 0.917) with good calibration. A sensitivity analysis yielded a preoperative-only model with highly comparable performance (AUC = 0.898). Decision curve analysis supported the use of a 20% risk threshold, at which the model achieved 93.9% sensitivity, 59.5% specificity, and a negative predictive value of 87.7%. It also confirmed a superior clinical net benefit compared to axillary sonography alone or default strategies. Our nomogram offers a practical, noninvasive tool to guide personalized axillary management in Egyptian patients with breast cancer, supporting risk-stratified decisions that may safely reduce unnecessary axillary surgery and align with global de-escalation principles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.